Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Hallucinogens and Psychedelics01:27

Hallucinogens and Psychedelics

771
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
771
CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

855
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
855
Modified-Release Drug Delivery Systems: Stimuli-Activated01:30

Modified-Release Drug Delivery Systems: Stimuli-Activated

26
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
26

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Targeted Protein Degradation and Metabolic Inhibition as Complementary Therapeutic Strategies: TEAD PROTACs and NAT8L Inhibitors in Oncology.

ACS medicinal chemistry letters·2026
Same author

Degrading Immune Checkpoints and Coordinating Oncogenic Signaling: Emerging Strategies in Cancer Therapy.

ACS medicinal chemistry letters·2026
Same authorSame journal

Degradation and Detection: Integrating BCL6 Targeted Protein Degradation with Biomarker-Guided BET Inhibition in Cancer.

ACS medicinal chemistry letters·2026
Same authorSame journal

Controlling Neuroplasticity Across Scales: Constrained Serotonergic Agonists, Neuroplastogens, and Adaptive Neuromodulation.

ACS medicinal chemistry letters·2026
Same author

Acyclic Glutarimide PROTAC Precursors Enable Controlled Protein Degradation and Expand Cereblon Ligand Space.

ACS medicinal chemistry letters·2026
Same author

Selective Induction of Estrogen Receptor-Dependent Stress Signaling as a Therapeutic Strategy in Resistant Breast Cancer.

ACS medicinal chemistry letters·2026
Same journal

Semisynthesis of Mycothiazole Analogs having Distinct Bioactivity.

ACS medicinal chemistry letters·2026
Same journal

Investigation on the Cytotoxicity of Hydroxycinnamic and Hydroxybenzoic Acid-Based Natural Antioxidant Conjugated Terpyridine Analogues toward Triple-Negative Breast Cancer.

ACS medicinal chemistry letters·2026
Same journal

Beyond Neddylation Inhibition: X‑ray Structures Reveal Carbonic Anhydrase Isoform Selectivity of Pevonedistat.

ACS medicinal chemistry letters·2026
Same journal

Structure-Guided Discovery of Selective Polo-Like Kinase 3 Inhibitors.

ACS medicinal chemistry letters·2026
查看所有相关文章

相关实验视频

Updated: Feb 19, 2026

Reproducible Manufacturing of SPOT as a High-throughput Scaffold-based Culture Platform
06:22

Reproducible Manufacturing of SPOT as a High-throughput Scaffold-based Culture Platform

Published on: July 29, 2025

980

从固态控制到预测精度:构建一个可部署的生态系统,用于迷幻疗法.

Anna C Renner1, Robert B Kargbo2

  • 1North Dakota State University, Fargo, North Dakota 58108-6050, United States.

ACS medicinal chemistry letters
|February 18, 2026
PubMed
概括
此摘要是机器生成的。

迷幻药物开发正在推进新的治疗系统. 创新包括优化药物稳定性和使用人工智能来预测患者的反应,解决迷幻医学的关键挑战.

更多相关视频

Generating Controlled, Dynamic Chemical Landscapes to Study Microbial Behavior
10:07

Generating Controlled, Dynamic Chemical Landscapes to Study Microbial Behavior

Published on: January 31, 2020

6.7K
Robotic Sensing and Stimuli Provision for Guided Plant Growth
08:02

Robotic Sensing and Stimuli Provision for Guided Plant Growth

Published on: July 1, 2019

8.6K

相关实验视频

Last Updated: Feb 19, 2026

Reproducible Manufacturing of SPOT as a High-throughput Scaffold-based Culture Platform
06:22

Reproducible Manufacturing of SPOT as a High-throughput Scaffold-based Culture Platform

Published on: July 29, 2025

980
Generating Controlled, Dynamic Chemical Landscapes to Study Microbial Behavior
10:07

Generating Controlled, Dynamic Chemical Landscapes to Study Microbial Behavior

Published on: January 31, 2020

6.7K
Robotic Sensing and Stimuli Provision for Guided Plant Growth
08:02

Robotic Sensing and Stimuli Provision for Guided Plant Growth

Published on: July 1, 2019

8.6K

科学领域:

  • 药理学 药理学是指药理学的学科.
  • 神经科学是一个神经科学.
  • 生物技术是生物技术.

背景情况:

  • 迷幻药物开发正在发展,超越了传统的分子和经验方法.
  • 翻译研究在制造,稳定性和预测治疗疗效方面面临瓶.

研究的目的:

  • 通过两个专利申请,突出心理治疗系统的最新进展.
  • 展示创新策略,以克服心理医学中的翻译挑战.

主要方法:

  • 对lysergamide类似物进行固态优化,以提高可制造性和稳定性.
  • 机器学习驱动的神经生理生物标志物的应用,以预测患者对迷幻疗法的反应.

主要成果:

  • 专利申请显示,在制造稳定,可制造的迷幻药物配方方面取得了进展.
  • 使用机器学习的预测生物标志物的开发增强了个性化的迷幻治疗方法.

结论:

  • 迷幻医学正在向综合治疗系统迈进.
  • 这些进展解决了关键的制造和患者分层挑战,为更广泛的临床应用铺平了道路.